We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$150M
Turnover
34.48%
1-Year Est. Return
17.71%
This Fund
S&P 500
This Quarter
Est. Return
+13.36%
1 Year Est. Return
+17.71%
3 Year Est. Return
+103.24%
5 Year Est. Return
+155.85%
10 Year Est. Return
+1,056.65%
AUM
$170M
AUM Growth
-$31.6M
(-16%)
Cap. Flow
-$50.5M
Cap. Flow
% of AUM
-29.77%
Top 10 Holdings %
Top 10 Hldgs %
63.38%
Holding
34
New
5
Increased
3
Reduced
13
Closed
9
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.15M |
| 2 |
Citigroup
C
|
+$6.43M |
| 3 |
Eli Lilly
LLY
|
+$5.68M |
| 4 |
Mastercard
MA
|
+$3.82M |
| 5 |
Microsoft
MSFT
|
+$3.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$10.3M |
| 2 |
Spotify
SPOT
|
+$9.77M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$9.44M |
| 4 |
Uber
UBER
|
+$9.36M |
| 5 |
SpringWorks Therapeutics
SWTX
|
+$7.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.43% |
| 2 | Healthcare | 31.26% |
| 3 | Financials | 20.32% |
| 4 | Technology | 12.02% |
| 5 | Miscellaneous | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Morgan Stanley
MS
$286B
| $21.6M | 12.77% |
153,693
-34,021
| -18% | -$4.18M |
2017 Q1
33 quarters
|
|
|
2
Uber
UBER
$146B
| $11.9M | 7.03% |
127,829
-113,642
| -47% | -$9.36M |
2020 Q2
20 quarters
|
|
3
Amazon
AMZN
$2.75T
| $11.7M | 6.92% |
53,471
-10,043
| -16% | -$1.99M |
2024 Q1
5 quarters
|
|
4
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $11.6M | 6.87% |
695,000
| – | – |
2017 Q1
33 quarters
|
|
5
Pfizer
PFE
$168B
| $9.91M | 5.84% |
408,728
-57,331
| -12% | -$1.34M |
2023 Q4
6 quarters
|
|
6
Bath & Body Works
BBWI
$4.12B
| $9.01M | 5.31% |
300,619
-45,996
| -13% | -$1.35M |
2023 Q2
8 quarters
|
|
|
7
Nike
NKE
$55.2B
| $8.47M | 4.99% |
+119,165
| New | +$7.15M |
2025 Q2
0 quarters
|
|
|
8
Vertex Pharmaceuticals
VRTX
$129B
| $8.36M | 4.93% |
18,778
-22,272
| -54% | -$10.3M |
2023 Q2
8 quarters
|
|
|
9
Citigroup
C
$207B
| $7.57M | 4.47% |
+88,950
| New | +$6.43M |
2025 Q2
0 quarters
|
|
10
Novo Nordisk
NVO
$173B
| $7.2M | 4.25% |
104,386
-17,214
| -14% | -$1.17M |
2025 Q1
1 quarter
|
|
11
Caesars Entertainment
CZR
$5.96B
| $7.04M | 4.15% |
247,851
-16,874
| -6% | -$459K |
2016 Q4
34 quarters
|
|
12
Flutter Entertainment
FLUT
$13.2B
| $7M | 4.13% |
24,484
-4,182
| -15% | -$1.03M |
2025 Q1
1 quarter
|
|
13
Wynn Resorts
WYNN
$7.93B
| $6.27M | 3.7% |
66,895
-11,143
| -14% | -$946K |
2024 Q3
3 quarters
|
|
|
14
Microsoft
MSFT
$4.01T
| $6.12M | 3.61% |
12,300
+8,070
| +191% | +$3.5M |
2023 Q4
6 quarters
|
|
|
15
Eli Lilly
LLY
$1.12T
| $5.7M | 3.36% |
+7,307
| New | +$5.68M |
2025 Q2
0 quarters
|
|
16
DELISTED
Masimo
MASI
| $5.66M | 3.34% |
33,641
-5,659
| -14% | -$904K |
2025 Q1
1 quarter
|
|
|
17
Mastercard
MA
$540B
| $5.23M | 3.09% |
9,310
+6,910
| +288% | +$3.82M |
2024 Q4
2 quarters
|
|
18
iShares Bitcoin Trust
IBIT
$66.2B
| $5.09M | 3% |
83,119
| – | – |
2024 Q3
3 quarters
|
|
19
Artivion
AORT
$1.07B
| $4.12M | 2.43% |
132,588
+68,288
| +106% | +$1.85M |
2025 Q1
1 quarter
|
|
20
Melco Resorts & Entertainment
MLCO
$1.64B
| $3.78M | 2.23% |
522,966
-441,678
| -46% | -$2.57M |
2022 Q3
11 quarters
|
|
21
Madison Square Garden
MSGS
$9.74B
| $2.73M | 1.61% |
+13,072
| New | +$2.52M |
2025 Q2
0 quarters
|
|
22
Toast
TOST
$18.6B
| $2.33M | 1.38% |
52,692
| – | – |
2022 Q3
11 quarters
|
|
23
NextDecade
NEXT
$1.6B
| $604K | 0.36% |
67,837
| – | – |
2023 Q4
6 quarters
|
|
24
Compass Pathways
CMPS
$1.61B
| $412K | 0.24% |
+147,209
| New | +$554K |
2025 Q2
0 quarters
|
|
25
DELISTED
Surrozen Inc Warrant
SRZNW
| $8K | ﹤0.01% |
442,052
-24,614
| -5% | -$544 |
2021 Q3
15 quarters
|
|
Similar funds
KCM
NMCM
IVGAI
PIP
AWA
QA
TPW
PA
Bridger Management's Q2 2025 Portfolio in Review
As of Q2 2025, Bridger Management held 34 positions worth $170M, down 16% from $201M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Bridger Management withdrew a net $50.5M in Q2 2025, closing 9 positions and reducing 13 holdings. Its most notable exit was Spotify, an estimated $9.77M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Bridger Management opened a new position in Nike worth $8.47M.
- Bridger Management's largest Q2 2025 buy was Nike: 119,165 shares worth $8.47M.
- Bridger Management added most to Mastercard in Q2 2025, an estimated $3.82M increase.
- Bridger Management's biggest Q2 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $10.3M.
- Bridger Management fully exited Spotify in Q2 2025, selling an estimated $9.77M.
- Bridger Management's ten largest holdings make up 63% of its $170M portfolio in Q2 2025.
- Bridger Management opened 5 new positions and closed 9 in Q2 2025.
- Bridger Management's portfolio value fell 16% quarter-over-quarter to $170M.
Based on Bridger Management's 13F filing for Q2 2025, filed 11 Aug 2025.